INT IMMUNOPHARMACOL 润色咨询

INTERNATIONAL IMMUNOPHARMACOLOGY

出版年份:2001 年文章数:5633 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    昨天 ms1000001286002339 来自四川省

    偏重的研究方向:免疫;炎症
    经验分享:记录状态:
    2024.03.15提交手稿
    2024.03.18With Editor
    发过一封催稿邮件没有回复

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    2024-02-28 12411d2dm22暂无昵称 来自河北省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:炎症;巨噬细胞;骨科
    经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    2023-11-22 liyu5975 来自陕西省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:免疫;炎症
    经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    2024-03-01 12570e4cm50暂无昵称

    12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    2024-03-20 ms5000000335651495 来自云南省

    审稿速度:1.0
    经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    2024-03-20 ms9000002114823480 来自福建省

    大家知道自己的编辑是谁吗?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    2024-03-21 零零一 来自广西

    #SCI#Accept

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    2024-02-21 yiyi11111111112 来自江苏省

    20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    2024-02-06 14778916m81暂无昵称 来自广东省

    偏重的研究方向:免疫;药理学;炎症
    经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……

    11

    展开11条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向:免疫;炎症<br>经验分享:记录状态:<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189811, encodeId=4f6f218981181, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:炎症;巨噬细胞;骨科<br>经验分享:三个审稿人,每个审稿人8-10条意见,非常专业,效率很高,三个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8a02458802, createdName=12411d2dm22暂无昵称, createdTime=Wed Feb 28 09:19:40 CST 2024, time=2024-02-28, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2170197, encodeId=1dd921e019749, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;炎症<br>经验分享:10.05投稿 10.11送审 10.26审稿人完成审稿 10.31给出大修 11.05修回 11.15审稿人完成审稿 11.16接收 11.19清样 10.22在线发表 来还愿啦!效率很高的一个杂志,编辑和两位审稿人都很友好。修改后文章整体水平提升很大。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/YConHRH5GCtcFEWO7xCkB10VsePH8PlzvattQoVRIQ7KJg26g6PvbkD8nE6Gsic5Nub2HzA4TsvkTQqEYUoz7pw/132, createdBy=288f2160779, createdName=liyu5975, createdTime=Wed Nov 22 11:16:56 CST 2023, time=2023-11-22, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190285, encodeId=137b21902856d, content=12月30号返修回去,投稿链接1月27显示的2个审稿人已经完成审稿,但是到今天系统一直是RRC,咋办呀?能催编辑吗?我感觉编辑都忘记了。。。太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d9892565543, createdName=12570e4cm50暂无昵称, createdTime=Fri Mar 01 08:18:28 CST 2024, time=2024-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194365, encodeId=4820219436502, content=审稿速度:1.0<br>经验分享:审稿人意见“请修改文本格式,必要时使用连字符,使文章布局更加整洁易读”,这是什么意思?求指点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884b6159465, createdName=ms5000000335651495, createdTime=Wed Mar 20 22:39:15 CST 2024, time=2024-03-20, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2194329, encodeId=c62d21943297a, content=大家知道自己的编辑是谁吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65878460096, createdName=ms9000002114823480, createdTime=Wed Mar 20 17:21:49 CST 2024, time=2024-03-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2194400, encodeId=4fed219440008, content=<a href='/topic/show?id=0d6a159920a' target=_blank style='color:#2F92EE;'>#SCI#</a>Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15992, encryptionId=0d6a159920a, topicName=SCI)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Thu Mar 21 09:05:46 CST 2024, time=2024-03-21, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2188499, encodeId=bcf4218849934, content=20231212日投稿;1215送审;1月9号收到大修;2月2日返稿,2月14日接收,2月19日proof。大修要了所以WB原图,至少三次的。还是挺严格的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70e05493523, createdName=yiyi11111111112, createdTime=Wed Feb 21 13:52:06 CST 2024, time=2024-02-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2186259, encodeId=31eb21862594e, content=偏重的研究方向:免疫;药理学;炎症<br>经验分享:12.16日投稿,隔天under review,12.30第一个审稿人审回,一直到今天都木找到第二个审稿人……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Tue Feb 06 21:11:26 CST 2024, time=2024-02-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海)]
    2023-09-27 ms8000001070008739 来自上海

    9.22投稿,9.24 under review,邀请了9个审稿人,到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……

    6

    展开6条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分